The master mammalian circadian clock, located in the suprachiasmatic nucleus (SCN) maintains the proper phase relationship between circadian clocks located in tissues throughout the body and entrains the circadian system to the environment. The SCN is composed of individual neuronal oscillators linked by intercellular communication into a neural network that generates a robust and precise rhythm. The long-term goal of our research is to understand the intercellular signaling mechanisms that couple SCN neurons into a neural network that generates circadian rhythms. GABA is the most abundant neurotransmitter in the SCN, where it regulates light-induced phase shifts, synchronization of the dorsal and ventral SCN, synchronization of the circadian phase of individual SCN neurons, and the sensitivity of the circadian clock to light-entraining signals. The strength and functional consequences of GABA(A) receptor activation (whether inhibitory or excitatory) are dynamically regulated by the circadian clock. GABA activates postsynaptic GABA(A) receptors located at structurally specialized synapses, which mediates fast interneuronal communication and extrasynaptic receptors which mediate a tonic GABA current. However, it remains unknown how these two GABA currents regulate the activity and synchrony of the SCN neural network. We hypothesize that two membrane transporter families play critical roles in the regulation of the circadian activity of GABA neurotransmission in the SCN. The GABA transporters GAT-1 and GAT-3 regulate the amount and duration of neurotransmitter GABA in the synaptic cleft and extrasynaptic space. We recently demonstrated that in the SCN the GATs are only expressed in astrocytes suggesting that astrocytes play a vital role in regulating the physiological actions of GABA in the SCN network. The chloride cotransporters of the sodium-potassium- chloride (NKCC) and potassium-chloride (KCC) families control the intracellular Cl- concentration and the polarity and magnitude of the GABA(A) receptor-mediated current. In the adult SCN, GABA may serve as both an inhibitory and excitatory neurotransmitter. We propose that the circadian clock uses WNK/SPAK kinases and Ca2+- and cyclic AMP-activated kinases to regulate the activity of the Cl- cotransporters. The goal of this application is to understand better the regulation of GABAergic signaling and how GABA-mediated signaling contributes to the generation of circadian timing signals in the suprachiasmatic nucleus. To accomplish this goal, we will use single cell electrophysiological and imaging techniques together with transgenic mouse models to study GABAergic neurotransmission identified populations of SCN neurons and examine the roles that synaptic and tonic GABAergic neurotransmission and astrocytes play in synchronizing the circadian clocks of individual SCN neurons. We will also kinase signaling pathways in the circadian control of the polarity of GABA(A) receptor-mediated neurotransmission in the SCN and determine the role of the NKCC and KCC families of chloride cotransporters in regulating the synchronization of SCN neuronal oscillators.

Public Health Relevance

Humans are rhythmic creatures living in a society that has rigid schedules for work, school, and social activities often requiring them to work when their endogenous circadian clock is signaling it is time to sleep. Significant negative health outcomes are linked to alterations in the timing of the endogenous clock and the onset of sleep or activity. This proposal will examine the neurological mechanisms responsible for biological timing and identify possible targets for the therapeutic intervention of circadian based disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
High Priority, Short Term Project Award (R56)
Project #
2R56NS036607-15A1
Application #
9551737
Study Section
Neuroendocrinology, Neuroimmunology, Rhythms and Sleep Study Section (NNRS)
Program Officer
He, Janet
Project Start
1998-04-01
Project End
2019-08-31
Budget Start
2017-09-28
Budget End
2019-08-31
Support Year
15
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Neurosciences
Type
Overall Medical
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Klett, Nathan J; Allen, Charles N (2017) Intracellular Chloride Regulation in AVP+ and VIP+ Neurons of the Suprachiasmatic Nucleus. Sci Rep 7:10226
Matus-Ortega, Maura E; Leff Gelman, Philippe; Calva-Nieves, Juan C et al. (2017) Mexneurin is a novel precursor of peptides in the central nervous system of rodents. FEBS Lett 591:1627-1636
Moldavan, Mykhaylo G; Allen, Charles N (2013) GABAB receptor-mediated frequency-dependent and circadian changes in synaptic plasticity modulate retinal input to the suprachiasmatic nucleus. J Physiol 591:2475-90
Olsen, Reid H J; Allen, Charles N; Derkach, Victor A et al. (2013) Impaired memory and reduced sensitivity to the circadian period lengthening effects of methamphetamine in mice selected for high methamphetamine consumption. Behav Brain Res 256:197-204
Eastwood, Emily; Allen, Charles N; Raber, Jacob (2012) Effects of neonatal methamphetamine and thioperamide exposure on spatial memory retention and circadian activity later in life. Behav Brain Res 230:229-36
Irwin, Robert P; Allen, Charles N (2010) Neuropeptide-mediated calcium signaling in the suprachiasmatic nucleus network. Eur J Neurosci 32:1497-506